Beverly B Green1,2,3, Melissa L Anderson2, Andrea J Cook4, Jessica Chubak2,4, Sharon Fuller2, Richard T Meenan5, Sally W Vernon6. 1. Kaiser Permanente Washington, Seattle, Washington. 2. Kaiser Permanente Health Research Institute, Seattle, Washington. 3. University of Washington School of Medicine, Seattle, Washington. 4. University of Washington School of Public Health, Seattle, Washington. 5. Center for Health Research, Kaiser Permanente Northwest, Portland, Oregon. 6. University of Texas School of Public Health, Houston, Texas.
Abstract
BACKGROUND: Screening over many years is required to optimize reductions in colorectal cancer (CRC) mortality. However, no prior trials have compared strategies for obtaining long-term adherence. METHODS: Systems of Support to Increase Colorectal Cancer Screening and Follow-Up was implemented in an integrated health care organization in Washington State. Between 2008 and 2009, 4675 individuals aged 50 to 74 years were randomized to receive the usual care (UC), which included clinic-based strategies to increase CRC screening (arm 1), or, in years 1 and 2, mailings with a call-in number for colonoscopy and mailed fecal tests (arm 2), mailings plus brief telephone assistance (arm 3), or mailings and assistance plus nurse navigation (arm 4). Active-intervention subjects (those in arms 2, 3, and 4 combined) who were still eligible for CRC screening were randomized to mailings being stopped or continued in years 3 and 5. The time in compliance with CRC screening over 5 years was compared for persons assigned to any intervention and persons assigned to UC. Screening tests contributed time on the basis of national guidelines for screening intervals (fecal tests annually, sigmoidoscopy every 5 years, and colonoscopy every 10 years). RESULTS: All participants contributed data, but they were censored at disenrollment, death, the age of 76 years, or a diagnosis of CRC. Compared with UC participants, intervention participants had 31% more adjusted covered time over 5 years (incidence rate ratio, 1.31; 95% confidence interval, 1.25-1.37; covered time, 47.5% vs 62.1%). Fecal testing accounted for almost all additional covered time. CONCLUSIONS: In a health care organization with clinic-based activities to increase CRC screening, a centralized program led to increased CRC screening adherence over 5 years. Longer term data on screening adherence and its impact on CRC outcomes are needed. Cancer 2017;123:4472-80.
RCT Entities:
BACKGROUND: Screening over many years is required to optimize reductions in colorectal cancer (CRC) mortality. However, no prior trials have compared strategies for obtaining long-term adherence. METHODS: Systems of Support to Increase Colorectal Cancer Screening and Follow-Up was implemented in an integrated health care organization in Washington State. Between 2008 and 2009, 4675 individuals aged 50 to 74 years were randomized to receive the usual care (UC), which included clinic-based strategies to increase CRC screening (arm 1), or, in years 1 and 2, mailings with a call-in number for colonoscopy and mailed fecal tests (arm 2), mailings plus brief telephone assistance (arm 3), or mailings and assistance plus nurse navigation (arm 4). Active-intervention subjects (those in arms 2, 3, and 4 combined) who were still eligible for CRC screening were randomized to mailings being stopped or continued in years 3 and 5. The time in compliance with CRC screening over 5 years was compared for persons assigned to any intervention and persons assigned to UC. Screening tests contributed time on the basis of national guidelines for screening intervals (fecal tests annually, sigmoidoscopy every 5 years, and colonoscopy every 10 years). RESULTS: All participants contributed data, but they were censored at disenrollment, death, the age of 76 years, or a diagnosis of CRC. Compared with UC participants, intervention participants had 31% more adjusted covered time over 5 years (incidence rate ratio, 1.31; 95% confidence interval, 1.25-1.37; covered time, 47.5% vs 62.1%). Fecal testing accounted for almost all additional covered time. CONCLUSIONS: In a health care organization with clinic-based activities to increase CRC screening, a centralized program led to increased CRC screening adherence over 5 years. Longer term data on screening adherence and its impact on CRC outcomes are needed. Cancer 2017;123:4472-80.
Authors: Richard T Meenan; Melissa L Anderson; Jessica Chubak; Sally W Vernon; Sharon Fuller; Ching-Yun Wang; Beverly B Green Journal: Am J Prev Med Date: 2015-06 Impact factor: 5.043
Authors: Enrique Quintero; Antoni Castells; Luis Bujanda; Joaquín Cubiella; Dolores Salas; Ángel Lanas; Montserrat Andreu; Fernando Carballo; Juan Diego Morillas; Cristina Hernández; Rodrigo Jover; Isabel Montalvo; Juan Arenas; Eva Laredo; Vicent Hernández; Felipe Iglesias; Estela Cid; Raquel Zubizarreta; Teresa Sala; Marta Ponce; Mercedes Andrés; Gloria Teruel; Antonio Peris; María-Pilar Roncales; Mónica Polo-Tomás; Xavier Bessa; Olga Ferrer-Armengou; Jaume Grau; Anna Serradesanferm; Akiko Ono; José Cruzado; Francisco Pérez-Riquelme; Inmaculada Alonso-Abreu; Mariola de la Vega-Prieto; Juana Maria Reyes-Melian; Guillermo Cacho; José Díaz-Tasende; Alberto Herreros-de-Tejada; Carmen Poves; Cecilio Santander; Andrés González-Navarro Journal: N Engl J Med Date: 2012-02-23 Impact factor: 91.245
Authors: Aasma Shaukat; Steven J Mongin; Mindy S Geisser; Frank A Lederle; John H Bond; Jack S Mandel; Timothy R Church Journal: N Engl J Med Date: 2013-09-19 Impact factor: 91.245
Authors: Beverly B Green; Melissa L Anderson; Jessica Chubak; Laura Mae Baldwin; Leah Tuzzio; Sheryl Catz; Alison Cole; Sally W Vernon Journal: J Am Board Fam Med Date: 2016 Mar-Apr Impact factor: 2.657
Authors: Michael Bretthauer; Michal F Kaminski; Magnus Løberg; Ann G Zauber; Jaroslaw Regula; Ernst J Kuipers; Miguel A Hernán; Eleanor McFadden; Annike Sunde; Mette Kalager; Evelien Dekker; Iris Lansdorp-Vogelaar; Kjetil Garborg; Maciej Rupinski; Manon C W Spaander; Marek Bugajski; Ole Høie; Tryggvi Stefansson; Geir Hoff; Hans-Olov Adami Journal: JAMA Intern Med Date: 2016-07-01 Impact factor: 21.873
Authors: Manon van der Vlugt; Esmée J Grobbee; Patrick Mm Bossuyt; Evelien Bongers; Wolfert Spijker; Ernst J Kuipers; Iris Lansdorp-Vogelaar; Marie-Louise Essink-Bot; Manon C W Spaander; Evelien Dekker Journal: Br J Cancer Date: 2016-12-06 Impact factor: 7.640
Authors: Jennifer K Coury; Jennifer L Schneider; Beverly B Green; Laura-Mae Baldwin; Amanda F Petrik; Jennifer S Rivelli; Malaika R Schwartz; Gloria D Coronado Journal: Transl Behav Med Date: 2020-02-03 Impact factor: 3.046
Authors: Nirupa R Ghai; Christopher D Jensen; Sophie A Merchant; Joanne E Schottinger; Jeffrey K Lee; Jessica Chubak; Aruna Kamineni; Ethan A Halm; Celette Sugg Skinner; Jennifer S Haas; Beverly B Green; Nancy T Cannizzaro; Jennifer L Schneider; Douglas A Corley Journal: Cancer Prev Res (Phila) Date: 2020-07-15
Authors: Caitlin C Murphy; Ahana Sen; Bianca Watson; Samir Gupta; Helen Mayo; Amit G Singal Journal: Cancer Epidemiol Biomarkers Prev Date: 2019-11-18 Impact factor: 4.254
Authors: Jessica Chubak; Melissa L Anderson; Andrea J Cook; Caitlin C Murphy; Michael L Jackson; Beverly B Green Journal: Cancer Epidemiol Biomarkers Prev Date: 2020-05-28 Impact factor: 4.254
Authors: Amanda F Petrik; Beverly Green; Jennifer Schneider; Edward J Miech; Jennifer Coury; Sally Retecki; Gloria D Coronado Journal: J Gen Intern Med Date: 2020-10-26 Impact factor: 5.128
Authors: Chyke A Doubeni; Stacey A Fedewa; Theodore R Levin; Christopher D Jensen; Chelsea Saia; Alexis M Zebrowski; Virginia P Quinn; Katharine A Rendle; Ann G Zauber; Tracy A Becerra-Culqui; Shivan J Mehta; Robert H Fletcher; Joanne Schottinger; Douglas A Corley Journal: Gastroenterology Date: 2018-09-27 Impact factor: 22.682
Authors: Jennifer L Schneider; Heather Spencer Feigelson; Virginia P Quinn; Carmit McMullen; Pamela A Pawloski; John D Powers; Andrew T Sterrett; David Arterburn; Douglas A Corley Journal: Perm J Date: 2020